Biotechnology and Medical Research (TRBC)

Regeneron-Sanofi drug succeeds mid-stage study

Regeneron-Sanofi drug succeeds mid-stage study

Published 16/10/2017

Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat inflammation in the esophagus, mainly caused by food allergies, met the main goal of a mid-stage study. [more…]

Exelixis drug improves overall survival in liver cancer patients

Exelixis drug improves overall survival in liver cancer patients

Published 16/10/2017

Exelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert group to recommend no further trial, sending the company's shares soaring 31 percent. [more…]

FDA panel backs gene therapy for rare form of blindness

FDA panel backs gene therapy for rare form of blindness

Published 12/10/2017

Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease. [more…]

U.S. NIH, 11 drugmakers partner to accelerate cancer therapy research

U.S. NIH, 11 drugmakers partner to accelerate cancer therapy research

Published 12/10/2017

The Trump Administration threw its support behind a public-private partnership with 11 drug companies to advance a new class of drugs that uses the body's immune system to fight cancer. [more…]

Flexion`s knee pain drug gets FDA nod, shares hit life high

Flexion`s knee pain drug gets FDA nod, shares hit life high

Published 06/10/2017

Flexion Therapeutics Inc said its injectable drug to treat osteoarthritis-related knee pain was approved by the U.S. Food and Drug Administration, sending the drug developer's shares soaring to a record high in regular trading on Friday. [more…]

New Jersey sues Insys as opioid maker settles with Massachusetts

New Jersey sues Insys as opioid maker settles with Massachusetts

Published 05/10/2017

New Jersey on Thursday accused Insys Therapeutics Inc of engaging in a fraudulent scheme to boost sales of a fentanyl-based cancer pain drug, as Massachusetts announced a $500,000 settlement with the drugmaker to resolve similar allegations. [more…]

Lilly wins Alimta patent dispute in U.S.

Lilly wins Alimta patent dispute in U.S.

Published 05/10/2017

The U.S. Patent and Trademark Office ruled in favor of Eli Lilly and Co in a patent dispute over its cancer drug Alimta with Neptune Generics LLC and Sandoz Inc. [more…]

Microscope trailblazers win chemistry Nobel for `freeze framing` life

Microscope trailblazers win chemistry Nobel for `freeze framing` life

Published 04/10/2017

A trio of Swiss, American and British scientists won the 2017 Nobel chemistry prize on Wednesday for developing cryo-electron microscopy, allowing researchers to see biological molecules frozen in action. [more…]

Oxford team to test universal flu vaccine in world first

Oxford team to test universal flu vaccine in world first

Published 03/10/2017

A seasonal flu vaccine that would be the first in the world to fight all types of the virus is to be tested in a two-year clinical trial involving more than 2,000 patients by researchers in Oxford. [more…]

FDA aims to speed up arrival of complex generic drugs

FDA aims to speed up arrival of complex generic drugs

Published 02/10/2017

The U.S. Food and Drug Administration on Monday announced a series of measures designed to speed to market generic versions of complex drugs such as Mylan NV's emergency EpiPen in an effort to address the rising cost of pharmaceuticals. [more…]